6-hydroxychlorzoxazone has been researched along with Cancer of Ovary in 1 studies
6-hydroxychlorzoxazone: chlorzoxazone metabolite in humans
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with advanced stage ovarian cancer and healthy volunteers were recruited." | 2.90 | Altered cytochrome 2E1 and 3A P450-dependent drug metabolism in advanced ovarian cancer correlates to tumour-associated inflammation. ( Aboagye, EO; Clarke, S; Edwards, RJ; Lee, P; Liddle, C; Lozan-Kuehne, JP; Maslen, L; Ramaswami, R; Sharma, R; Trousil, S, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trousil, S | 1 |
| Lee, P | 1 |
| Edwards, RJ | 1 |
| Maslen, L | 1 |
| Lozan-Kuehne, JP | 1 |
| Ramaswami, R | 1 |
| Aboagye, EO | 1 |
| Clarke, S | 1 |
| Liddle, C | 1 |
| Sharma, R | 1 |
1 trial available for 6-hydroxychlorzoxazone and Cancer of Ovary
| Article | Year |
|---|---|
Altered cytochrome 2E1 and 3A P450-dependent drug metabolism in advanced ovarian cancer correlates to tumour-associated inflammation.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Caffeine; Chlorzoxazone; Cytochrome P-450 Enzyme | 2019 |